| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 64.87▲ | 64.68▲ | 64.70▲ | 64.15▲ | 63.93▲ |
| MA10 | 64.81▲ | 64.60▲ | 64.64▲ | 63.00▲ | 62.54▲ |
| MA20 | 64.68▲ | 64.63▲ | 64.66▲ | 63.39▲ | 62.28▲ |
| MA50 | 64.61▲ | 64.48▲ | 63.19▲ | 62.07▲ | 68.16▼ |
| MA100 | 64.61▲ | 63.04▲ | 63.07▲ | 61.96▲ | 73.80▼ |
| MA200 | 64.63▲ | 63.10▲ | 62.92▲ | 66.22▼ | 74.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.026▲ | 0.004▲ | -0.076▼ | 0.165▲ | 0.885▲ |
| RSI | 60.985▲ | 60.794▲ | 62.915▲ | 61.995▲ | 52.363▲ |
| STOCH | 82.311▲ | 75.757 | 61.213 | 73.396 | 86.299▲ |
| WILL %R | -20.561▲ | -12.291▲ | -12.291▲ | -4.312▲ | -2.838▲ |
| CCI | 113.501▲ | 180.685▲ | 129.741▲ | 91.507 | 142.615▲ |
|
Wednesday, April 24, 2024 11:26 AM
Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted for oral presentation –– Additional data from the Phase 3 DeFi trial of ...
|
|
Tuesday, April 23, 2024 09:00 AM
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation ...
|
|
Tuesday, April 23, 2024 09:00 AM
Leidos Holdings, Inc. engages in the provision of services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/04/24 | 64.01 | 65.03 | 63.77 | 64.93 | 330,294 |
| 23/04/24 | 64.21 | 64.99 | 64.21 | 64.51 | 287,090 |
| 22/04/24 | 64.19 | 65.14 | 63.885 | 64.64 | 312,578 |
| 19/04/24 | 62.19 | 64.62 | 62.19 | 64.39 | 506,121 |
| 18/04/24 | 61.75 | 62.48 | 61.46 | 62.29 | 259,104 |
| 17/04/24 | 61.53 | 61.86 | 61.075 | 61.45 | 301,813 |
| 16/04/24 | 61.60 | 61.60 | 60.27 | 61.06 | 297,256 |
| 15/04/24 | 61.80 | 62.115 | 61.035 | 61.97 | 528,743 |
| 12/04/24 | 62.19 | 62.55 | 61.27 | 62.08 | 473,120 |
| 11/04/24 | 63.46 | 63.46 | 62.37 | 62.71 | 330,445 |
|
|
||||
|
|
||||
|
|